EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Reassuring humoral and cellular immune responses to SARS-CoV-2 vaccination in participants with systemic sclerosis

Jenna M Benoit, Jessica A Breznik, Angela Huynh, Braeden Cowbrough, Barbara Baker, Lauren Heessels, Sumiya Lodhi, Elizabeth Yan, Hina Bhakta, Rumi Clare, Ishac Nazy, Jonathan L Bramson und 2 weitere

Immunology Letters · 2024

DOI: 10.1016/j.imlet.2024.106929 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunology Letters, 2024. Verfasst von Jenna M Benoit und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, McMaster University, Hamilton, Ontario, Canada; McMaster Immunology Research Centre, Hamilton, Ontario, Canada; Firestone Ins…. Hauptthemen laut MEDLINE: Scleroderma, Systemic, SARS-CoV-2, Immunity, Humoral, COVID-19. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Individuals with systemic sclerosis (SSc) are particularly susceptible to SARS-CoV-2 infections, yet it remains to be determined if they generate humoral and cellular responses comparable to controls following SARS-CoV-2 vaccinations. Herein, we collected blood and serum after second, third, and fourth SARS-CoV-2 vaccinations in patients with SSc and controls. Following each dose, participants with SSc mounted comparable serum anti-RBD IgG, anti-RBD IgA, and spike-specific CD4+ and CD8+T cell responses to those found in controls. At 3 months post dose 2, the frequencies of Th1, Th2, Th17, and Treg spike-specific CD4+T cells in participants with SSc did not differ from controls. At 2-6 weeks post dose 3, participants with SSc displayed reduced frequencies, but not numbers, of Th17-polarized spike-specific CD4+T cells. Thus, participants with SSc did not display significantly weaker humoral or cellular responses to SARS-CoV-2 vaccination than controls, enabling reassurance of vaccine immunogenicity in participants with SSc.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Scleroderma, SystemicSARS-CoV-2Immunity, HumoralCOVID-19COVID-19 VaccinesImmunity, CellularAntibodies, ViralVaccinationHumansMiddle AgedFemaleMaleAgedAdultSpike Glycoprotein, CoronavirusImmunoglobulin GBNT162 VaccineImmunoglobulin ACD8-Positive T-LymphocytesImmunogenicity, Vaccine

Stichwörter der Autor:innen

Autoimmune diseasesCOVID-19SARS-CoV-2Systemic sclerosisVaccines

Substanzen

COVID-19 VaccinesAntibodies, ViralSpike Glycoprotein, CoronavirusImmunoglobulin GBNT162 Vaccinespike protein, SARS-CoV-2Immunoglobulin A

Autor:innen und Institutionen

  • Department of Medicine, McMaster University, Hamilton, Ontario, Canada; McMaster Immunology Research Centre, Hamilton, Ontario, Canada; Firestone Institute of Respiratory Health, St. Joseph's Healthcare, Hamilton, Ontar…
  • Department of Medicine, McMaster University, Hamilton, Ontario, Canada; McMaster Immunology Research Centre, Hamilton, Ontario, Canada; McMaster Institute for Research on Aging, McMaster University, Hamilton, Ontario, C…
  • Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Department of Medicine, McMaster University, Hamilton, Ontario, Canada; McMaster Immunology Research Centre, Hamilton, Ontario, Canada.
  • Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
  • Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Electronic address: mlarche@mcmaster.ca.

Zitieren

APA

Benoit, J. M., Breznik, J. A., Huynh, A., Cowbrough, B., Baker, B., Heessels, L., Lodhi, S., Yan, E., Bhakta, H., Clare, R., Nazy, I., Bramson, J. L., Larché, M. J., & Bowdish, D. M. (2024). Reassuring humoral and cellular immune responses to SARS-CoV-2 vaccination in participants with systemic sclerosis. Immunology Letters. https://doi.org/10.1016/j.imlet.2024.106929

Vancouver

Benoit JM, Breznik JA, Huynh A, Cowbrough B, Baker B, Heessels L, et al. Reassuring humoral and cellular immune responses to SARS-CoV-2 vaccination in participants with systemic sclerosis. Immunology Letters. 2024. doi:10.1016/j.imlet.2024.106929

BibTeX
@article{Benoit2024,
  author = {Benoit, Jenna M and Breznik, Jessica A and Huynh, Angela and Cowbrough, Braeden and Baker, Barbara and Heessels, Lauren and Lodhi, Sumiya and Yan, Elizabeth and Bhakta, Hina and Clare, Rumi and Nazy, Ishac and Bramson, Jonathan L and Larché, Maggie J and Bowdish, Dawn Me},
  title = {Reassuring humoral and cellular immune responses to SARS-CoV-2 vaccination in participants with systemic sclerosis},
  journal = {Immunology Letters},
  year = {2024},
  doi = {10.1016/j.imlet.2024.106929}
}
Kostenlos starten →